Title:
USE OF INTERFERENCE POLYPEPTIDE IN PREPARATION OF ANTI-SARS-COV-2 DRUG
Document Type and Number:
WIPO Patent Application WO/2021/258250
Kind Code:
A1
Abstract:
Provided is a medicament for inhibiting the binding of a transferrin receptor and a SARS-CoV-2 spike protein, or an anti-SARS-CoV-2 drug, which is characterized in that active ingredients of the medicament or drug comprise an interference polypeptide, and the polypeptide comprises SL8, FG8, DL12, RK4, SD6, HF7 and/or QK8.
More Like This:
| JP5713211 | Temporin-SHa analogs and their use |
| JP2013533848 | Compounds, drugs and treatments for Helicobacter pylori infection |
| WO/1987/006940 | ASSAYS AND ANTIBODIES FOR N-myc PROTEINS |
Inventors:
LAI REN (CN)
TANG XIAOPENG (CN)
LIAO ZHIYI (CN)
TANG XIAOPENG (CN)
LIAO ZHIYI (CN)
Application Number:
PCT/CN2020/097446
Publication Date:
December 30, 2021
Filing Date:
June 22, 2020
Export Citation:
Assignee:
KUNMING INST ZOOLOGY CAS (CN)
International Classes:
C07K7/08; A61K38/07; A61K38/08; A61K38/10; A61P31/14; C07K5/11; C07K7/06
Foreign References:
| CN1488641A | 2004-04-14 |
Other References:
CAVEZZI ATTILIO, TROIANI EMIDIO, CORRAO SALVATORE: "COVID-19: Hemoglobin, Iron, and Hypoxia beyond Inflammation. A Narrative Review", CLINICS AND PRACTICE, vol. 10, no. 2, 28 May 2020 (2020-05-28), pages 24 - 30, XP055882438, DOI: 10.4081/cp.2020.1271
DATABASE PROTEIN 23 March 2015 (2015-03-23), ANONYMOUS : "transferrin receptor (p90, CD71), isoform CRA_b [Homo sapiens]", XP055882442, retrieved from NCBI Database accession no. EAW53671
DATABASE PROTEIN 23 March 2015 (2015-03-23), ANONYMOUS : "transferrin receptor (p90, CD71), isoform CRA_b [Homo sapiens]", XP055882442, retrieved from NCBI Database accession no. EAW53671
Attorney, Agent or Firm:
BEIJING GAOWO LAW FIRM (CN)
Download PDF: